N/A
N=93
Neuroplastic Mechanisms Underlying Augmented Neuromuscular Training
Anterior Cruciate Ligament Injuries
Bottom Line
View on ClinicalTrials.gov: NCT04069520 ↗Enrolled (actual)
93
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcome: Primary: Neural Mechanisms for Injury-resistant Movement Pattern Acquisition — 0.28; 0.26; 0.26; 0.21 % BOLD Signal change
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- aNMT Biofeedback (Other); Sham Biofeedback (Other)
- Age
- Pediatric, Adult · 12+ yrs
- Sex
- Female
- Sponsor
- Emory University
- Primary completion
- Aug 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Neural Mechanisms for Injury-resistant Movement Pattern Acquisition |
0.28; 0.26; 0.26; 0.21 | — |
| PRIMARY Knee Joint Biomechanics During Landing Task |
83.49; 80.50; 86.06; 83.48 | — |
| SECONDARY Neural Mechanisms for Injury-resistant Movement Pattern Transfer to VR-simulated Sport |
0.31; 0.26; 0.26; 0.31 | — |
| SECONDARY Knee Joint Biomechanics During VR-simulated Sport |
68.43; 68.93; 73.27; 71.89 | — |
Summary
The purpose of this study is to determine the neural mechanisms of augmented neuromuscular training (aNMT). Participants will complete a 6-week course of neuromuscular training with either aNMT biofeedback or sham biofeedback. An MRI will be performed before and after the training program.
Eligibility Criteria
Inclusion Criteria
- enrolled in parent study "Real-time Sensorimotor Feedback for Injury Prevention Assessed in Virtual Reality"
Exclusion Criteria
- contraindications to MRI scan
Data sourced from ClinicalTrials.gov (NCT04069520). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.